National Academies Press: OpenBook
« Previous: B12. ANtiprogestogens: Perspectives from a Global Research Program
Suggested Citation:"Appendix C: Observers at the Workshop on Antiprogestins." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
×

C
Observers at the Workshop on Antiprogestins: Assessing the Science April 13–14, 1993

Duane Alexander, M.D.

National Institute of Child Health and Human Development

National Institutes of Health

Freedolph Anderson, M.D.

The Jones Institute for Reproductive Medicine Norfolk, Virginia

Wendy Baldwin, Ph.D.

National Institute of Child Health and Human Development

National Institutes of Health

Jose Barzelatto, M.D.

The Ford Foundation

Marie Bass

Bass & Howe

Washington, D.C.

Gabriel Bialy

National Institute of Child Health and Human Development

National Institutes of Health

James Bilstad, M.D.

Food and Drug Administration

Deeda Blair

Lasker Foundation

Kristof Chwalisz, M.D.

Schering AG

Berlin, Germany

Francine Coeytaux, Ph.D.

Los Angeles, California

C. Edgar Cook, Ph.D.

Research Triangle Institute

Philip Corfman, M.D.

Food and Drug Administration

Horacio Croxatto, M.D.

Pontificia

Universidad Catolica de Chile

Robert B. Dickson, Ph.D.

Lombardi Cancer Research Center Georgetown University

Erlinda Etucbanas, M.D.

Berlex Laboratories Richmond, California

Suggested Citation:"Appendix C: Observers at the Workshop on Antiprogestins." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
×

Robin Foldesy, Ph.D.

Gynopharma, Inc. Somerville, New Jersey

Marilynn Frederiksen, M.D.

Northwestern University

Henry Gabelnick, Ph.D.

CONRAD

Arlington, Virginia

George Gaines

National Institute of Child Health and Human Development

National Institutes of Health

Dr. Dominique Garrel

Centre de Recherche Hôtel-Dieu de Montréal

Mark Graham II, M.D.

Lineberger Cancer Center

University of North Carolina

Forrest Greenslade, Ph.D.

IPAS

Carrboro, North Carolina

Steven Grunberg, M.D.

Comprehensive Cancer Center

University of Southern California

Florence Haseltine, M.D., Ph.D.

National Institute of Child Health and Human Development

National Institutes of Health

R. Brian Heap, Ph.D., Sc.D., F.R.S.

AFRC—Institute of Animal Physiology and Genetics Research Cambridge, England

Jennifer Jackman

Feminist Majority Washington, D.C.

Harold Kaminetzky, M.D.

American College of Obstetricians and Gynecologists

Paul Lammers, M.D.

Organon West Orange, New Jersey

John Lamont, M.D.

McMaster University

Roderick Mackenzie

Gynopharma, Inc. Somerville, New Jersey

Carolyn Makinson

Andrew Mellon Foundation

Donald McDonnell, Ph.D.

Ligand Pharmaceuticals, Inc.

La Jolla, California

Irwin Merkatz, M.D.

Albert Einstein School of Medicine

Ruth Merkatz, Ph.D.

Food and Drug Administration

Ana Murphy, M.D.

Emory University

Mary Pendergast

Food and Drug Administration

Audrey Phillips, Ph.D.

R.W. Johnson Pharmaceutical Research Institute Raritan, New Jersey

Michael Policar, M.D., M.P.H.

Planned Parenthood Federation of America New York, New York

William Regelson, M.D.

Medical College of Virginia

Suggested Citation:"Appendix C: Observers at the Workshop on Antiprogestins." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
×

Seymour Romney, M.D.

Albert Einstein School of Medicine

Sarah Samuels, Dr.P.H.

Henry J. Kaiser Family Foundation

Professor Gilbert Schiason

Hopital de Bicêtre Paris, France

Ekkehard Schillinger, M.D.

Schering AG Berlin, Germany

Sheldon Segal, Ph.D.

Population Council New York, New York

Solomon Sobel, M.D.

Food and Drug Administration

Jeff Spieler

Agency for International Development Washington, D.C.

Catherine Stika, M.D.

Northwestern University

Irene Stith-Coleman, Ph.D.

Congressional Research Service Washington, D.C.

Pamela Stratton, M.D.

National Institute of Child Health and Human Development

National Institutes of Health

Rosemarie Thau, Ph.D.

Population Council New York, New York

Helena von Hertzen, D.D.S., M.D.

World Health Organization Geneva, Switzerland

Charles Watlington, M.D., Ph.D.

Virginia Commonwealth University

Beverly Winikoff, M.D., M.P.H.

Population Council New York, New York

Susan Wood, Ph.D.

Congressional Caucus for Women's Issues Washington, D.C.

IOM STAFF

Kenneth Shine, M.D.

President

Enriqueta Bond, Ph.D.

Executive Officer

Michael Stoto, Ph.D.

Director, Division of Health Promotion and Disease Prevention

Ruth Bulger, Ph.D.

Director, Division of Health Sciences Policy

Molla Donaldson, M.S.

Study Director

Sarah Brown, M.P.H.

Senior Program Officer

Karen Foote

Commission on Behavioral and Social Sciences and Education (National Research Council)

Linda DePugh

Anna Mastroianni, J.D.

Terri Barba

Helen Rogers

Suggested Citation:"Appendix C: Observers at the Workshop on Antiprogestins." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
×
Page 278
Suggested Citation:"Appendix C: Observers at the Workshop on Antiprogestins." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
×
Page 279
Suggested Citation:"Appendix C: Observers at the Workshop on Antiprogestins." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
×
Page 280
Next: Index »
Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda Get This Book
×
Buy Paperback | $50.00
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Mifepristone (RU486), the first clinically available antiprogestin, has generated great interest since its discovery in the early 1980s. Today, it is recognized that mifepristone, along with other antiprogestins, has a potentially significant therapeutic role in human health and disease, with likely applicability to a variety of pregnancy-related conditions (e.g., management of labor) and to contraception, endometriosis, and cancer, among others. But because mifepristone has been studied and used most widely as a means of nonsurgical abortion, political issues have thus far limited research on the drug and prevented its introduction into the U.S. market.

This book provides an unbiased evaluation of current knowledge about both the fundamental nature of antiprogestins as well as their possible use in treating numerous diseases and conditions, and it contains recommendations for future research.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!